Two Items Key To Decrease Symptoms And Prolong Survival For Leptomeningeal Carcinomatosis Patients
4/24/2013
Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment...
New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced non-small cell lung cancer (NSCLC) harboring specific HER2 protein mutations...
Elderly Patients With Bone Metastases Benefit From Palliative Radiotherapy
4/24/2013
Giving palliative radiotherapy to elderly patients with painful bone metastases can significantly improve their quality of life, a Dutch researcher told the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO)...
Discovery of Metastasis Stem Cells In The Blood Of Breast Cancer Patients
4/24/2013
Individual cancer cells that break away from the original tumor and circulate through the blood stream are considered responsible for the development of metastases. These dreaded secondary tumors are the main cause of cancer-related deaths. Circulating tumor cells (CTCs) detectable in a patient's blood are associated with a poorer prognosis...
Ovarian Cancer May Be Detected Early By Testing Cells From Uterus Or Cervix
4/24/2013
Pioneering biophotonics technology developed in the US can detect nanoscale changes in cells from the cervix and uterus that may indicate early stage ovarian cancer, according to a study published this month in the International Journal of Cancer...
Breast Cancer Growth And Spread May Be Controlled By New Agent
4/24/2013
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs...
Researchers at Karolinska Institutet have developed a method for assessing the effect of tamoxifen, a common drug to prevent the relapse of breast cancer. The key lies in monitoring changes in the proportion of dense tissue, which appears white on a mammogram, during treatment...
Non-Melanoma Skin Cancer Linked To Future Risk Of Other Forms Of Cancers
4/23/2013
White people who have types of skin cancer other than melanoma (non-melanoma skin cancer) may be at increased risk of having other forms of cancer in the future, according to a study by US researchers published in this week's PLOS Medicine. The analysis, led by Dr...
Obese Men With Benign Biopsy At High Risk For Prostate Cancer
4/23/2013
Data on obesity and prostate cancer conflict. Precancerous lesions were more common in benign biopsy specimens from obese men. After benign biopsy, obese men at higher risk for future prostate cancer...
Ovarian Cancer May Be Detectable Early By Testing Cells From Uterus Or Cervix
4/23/2013
Pioneering biophotonics technology developed in the US can detect nanoscale changes in cells from the cervix and uterus that may indicate early stage ovarian cancer, according to a study published this month in the International Journal of Cancer...